Today it became known that the vaccine prepared for a long time from the pharmaceutical company Johnson Johnson's & Janssen today received official approval for wide distribution among a wide number of Americans, and from two agencies involved in the field of national health at once – we are talking about the approval of this vaccine on the part of the US FDA and the US Centers for Disease Control and Prevention, which was a really remarkable step on the part of the US national health system as it has a high priority.
It is worth noting the fact that this vaccine against coronavirus from the pharmaceutical company Johnson Johnson's & Janssen is something like a one-time version of the vaccine – which is administered almost instantly and does not require a second and even more so a third visit to the doctor after the first vaccination.
In this sense, the format is certainly convenient, since the leading experiments of the American health care system point to the fact that the biggest problem lies in the fact that few people in the United States are generally willing to go to the doctor again for vaccinations. With regard to the official approval of the distribution and use of this vaccine among a wide range of segments of the population in America, experts also express the opinion that its specific level of safety and will effectively be higher than previous samples from other pharmaceutical companies from Pfizer or Moderna. On the other hand, specialists still have to spend some time researching the side effects.
While the widespread integration of such a one-off vaccine can be said to be truly remarkable for the vast majority of people in the US, it is likely that in the future the FDA and CDC will provide some other data and decisions regarding the continued distribution of such a vaccine. All that remains is to wait for more or less proven sources of information on this matter and the opinions of leading experts in the US health care system.
VKontakt Facebo … Twitter Google+ Odno … Telegram